These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9185024

  • 1. Calcium channel blockers and cardiac mortality in the treatment of hypertension: a report from the Department of Health Hypertension Care Computing Project (DHCCP).
    Bulpitt CJ, Palmer AJ, Beevers DG, Coles EC, Ledingham JG, Petrie JC, Webster J.
    J Hum Hypertens; 1997 Apr; 11(4):205-11. PubMed ID: 9185024
    [Abstract] [Full Text] [Related]

  • 2. Calcium channel blockers, ACE inhibitors, and the risk of cancer in hypertensive patients: a report from the Department of Health Hypertension Care Computing Project (DHCCP).
    Stahl M, Bulpitt CJ, Palmer AJ, Beevers DG, Coles EC, Webster J.
    J Hum Hypertens; 2000 May; 14(5):299-304. PubMed ID: 10822315
    [Abstract] [Full Text] [Related]

  • 3. Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension.
    Tardif JC, Ducharme A, Yu H, Wogen J, Guertin MC.
    Clin Ther; 2004 Jul; 26(7):1073-83. PubMed ID: 15336472
    [Abstract] [Full Text] [Related]

  • 4. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S, Psaty B, Greenland P, Oberman A, Kotchen T, Mouton C, Black H, Aragaki A, Trevisan M.
    JAMA; 2004 Dec 15; 292(23):2849-59. PubMed ID: 15598916
    [Abstract] [Full Text] [Related]

  • 5. Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker-Induced Lower-Extremity Edema With Loop Diuretics.
    Vouri SM, Jiang X, Manini TM, Solberg LM, Pepine C, Malone DC, Winterstein AG.
    JAMA Netw Open; 2019 Dec 02; 2(12):e1918425. PubMed ID: 31880802
    [Abstract] [Full Text] [Related]

  • 6. Prospective study of calcium channel blocker use, cardiovascular disease, and total mortality among hypertensive women: the Nurses' Health Study.
    Michels KB, Rosner BA, Manson JE, Stampfer MJ, Walker AM, Willett WC, Hennekens CH.
    Circulation; 1998 Apr 28; 97(16):1540-8. PubMed ID: 9593558
    [Abstract] [Full Text] [Related]

  • 7. Beta-blockers for hypertension.
    Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH.
    Cochrane Database Syst Rev; 2017 Jan 20; 1(1):CD002003. PubMed ID: 28107561
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of a Common Prescribing Cascade of Calcium Channel Blockers and Diuretics in Older Adults With Hypertension.
    Savage RD, Visentin JD, Bronskill SE, Wang X, Gruneir A, Giannakeas V, Guan J, Lam K, Luke MJ, Read SH, Stall NM, Wu W, Zhu L, Rochon PA, McCarthy LM.
    JAMA Intern Med; 2020 May 01; 180(5):643-651. PubMed ID: 32091538
    [Abstract] [Full Text] [Related]

  • 9. Beta-blockers for hypertension.
    Wiysonge CS, Bradley H, Mayosi BM, Maroney R, Mbewu A, Opie LH, Volmink J.
    Cochrane Database Syst Rev; 2007 Jan 24; (1):CD002003. PubMed ID: 17253471
    [Abstract] [Full Text] [Related]

  • 10. Calcium channel blockers in hypertension: reappraisal after new trials and major meta-analyses.
    Opie LH.
    Am J Hypertens; 2001 Oct 24; 14(10):1074-81. PubMed ID: 11710789
    [Abstract] [Full Text] [Related]

  • 11. Dual calcium-channel blocker therapy in the treatment of hypertension.
    Saseen JJ, Carter BL.
    Ann Pharmacother; 1996 Oct 24; 30(7-8):802-10. PubMed ID: 8826565
    [Abstract] [Full Text] [Related]

  • 12. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GW, Wright JM.
    Cochrane Database Syst Rev; 2015 Jan 11; 1():CD008170. PubMed ID: 25577154
    [Abstract] [Full Text] [Related]

  • 13. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
    Tsai MS, Tang CH, Lin CY, Chuang PY, Chen NC, Huang CH, Chang WT, Wang TD, Yu PH, Chen WJ.
    Cardiovasc Drugs Ther; 2017 Dec 11; 31(5-6):535-543. PubMed ID: 29218625
    [Abstract] [Full Text] [Related]

  • 14. Rational pharmacotherapy of hypertension in the elderly: analysis of the choice and dosage of drugs.
    Jassim Al Khaja KA, Sequeira RP, Mathur VS.
    J Clin Pharm Ther; 2001 Feb 11; 26(1):33-42. PubMed ID: 11286605
    [Abstract] [Full Text] [Related]

  • 15. Long-term survival and use of antihypertensive medications in older persons.
    Pahor M, Guralnik JM, Corti MC, Foley DJ, Carbonin P, Havlik RJ.
    J Am Geriatr Soc; 1995 Nov 11; 43(11):1191-7. PubMed ID: 7594151
    [Abstract] [Full Text] [Related]

  • 16. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
    Bakris GL, Cooper-Dehoff RM, Zhou Q, Kupfer S, Champion A, Pepine CJ, INVEST Investigators.
    Am J Cardiovasc Drugs; 2007 Nov 11; 7 Suppl 1():25-9. PubMed ID: 19845074
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging.
    Maxwell CJ, Hogan DB, Ebly EM.
    CMAJ; 1999 Sep 07; 161(5):501-6. PubMed ID: 10497605
    [Abstract] [Full Text] [Related]

  • 20. Rate Control With Beta-blockers Versus Calcium Channel Blockers in the Emergency Setting: Predictors of Medication Class Choice and Associated Hospitalization.
    Atzema CL, Austin PC.
    Acad Emerg Med; 2017 Nov 07; 24(11):1334-1348. PubMed ID: 28853232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.